Phase III Study of Ocrelizumab in Patients with Primary Progressive Multiple Sclerosis: ORATORIO Study Design

被引：0
作者：
Montalban, Xavier
Wolinsky, Jerry
Yin, Ming
Leppert, David
Glanzman, Robert
Chin, Peter
机构：
来源：
NEUROLOGY | 2011年 / 76卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A319 / A320
页数：2
相关论文
共 50 条
  • [21] Beyond ocrelizumab in primary progressive multiple sclerosis
    Williams, Thomas
    Chataway, Jeremy
    NATURE REVIEWS NEUROLOGY, 2022, 18 (11) : 641 - 642
  • [22] SOCIOECONOMIC VALUE OF OCRELIZUMAB IN THE TREATMENT OF PATIENTS WITH PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
    Di Maio, D.
    Wu, J.
    Stavropoulos, A.
    Sanchez, Alvarez J.
    Diles, D.
    VALUE IN HEALTH, 2021, 24 : S161 - S161
  • [23] Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO
    Gibiansky, Ekaterina
    Petry, Claire
    Mercier, Francois
    Gunther, Andreas
    Herman, Ann
    Kappos, Ludwig
    Hauser, Stephen
    Yamamoto, Yumi
    Wang, Qing
    Model, Fabian
    Kletzl, Heidemarie
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (06) : 2511 - 2520
  • [24] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Craveiro, L.
    Hughes, R.
    McNamara, J.
    Pradhan, A.
    Wormser, D.
    Koendgen, H.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 317 - 318
  • [25] Real world experience with ocrelizumab in patients with primary progressive multiple sclerosis
    Lopez Ruiz, R.
    Dotor Garcia-Soto, J.
    Hiraldo, J. D. G.
    Ruiz-Pena, J. L.
    Paramo Camino, M. D.
    Ruiz De Arcos, M.
    Navarro Mascarell, G.
    Eichau Madueno, S.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 301 - 302
  • [26] Ocrelizumab in people with primary progressive multiple sclerosis: A real-world multicentric study
    Skoric, Magdalena Krbot
    Kes, Vanja Basic
    Grbic, Nevena
    Lazibat, Ines
    Pavelin, Sanda
    Zubonja, Tea Mirosevic
    Komso, Milica
    Piskac, Spomenka Kidemet
    Abicic, Ana
    Piskac, Dominik
    Adamec, Ivan
    Barun, Barbara
    Gabelic, Tereza
    Habek, Mario
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 89
  • [27] Relapsing-remitting and primary progressive multiple sclerosis treated with ocrelizumab: A comparative study
    de Antonio, Luis A. Rodriguez
    Cuberta-Gonzalez, Ines
    Garcia-Castanon, Inmaculada
    Oreja-Guevara, Celia
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 69
  • [28] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, Stephen L.
    Kappos, Ludwig
    Montalban, Xavier
    Chognot, Cathy
    Jessop, Nikki
    Pradhan, Ashish
    Prajapati, Kalpesh
    Wolinsky, Jerry S.
    NEUROLOGY, 2021, 96 (15)
  • [29] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Guittari, C. J.
    Koendgen, H.
    Li, C.
    Marcillat, C.
    Wormser, D.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 324 - 325
  • [30] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, Stephen
    Kappos, Ludwig
    Montalban, Xavier
    Koendgen, Harold
    Li, Carrie
    Marcillat, Carole
    Pradhan, Ashish
    Wormser, David
    Wolinsky, Jerry
    NEUROLOGY, 2018, 90
12345